Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1294-1300

  Smith McCune, K ^a   Zhu, Y H ^a   Hanahan, D ^a,b   Arbeit, J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; UTERINE CERVIX CARCINOMA;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MICE; MICE, TRANSGENIC; MICROCIRCULATION; NEOPLASMS, SQUAMOUS CELL; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0030989017     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res., 46: 467-473, 1986.
2. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
3. Chodak, G. W., Haudenschild, C., Gittes, R. F., and Folkman, J. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann. Surg., 192: 762-771, 1980.
4. Brem, S. S., Jensen, H. M., and Gullino, P. M. Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer (Phila.), 41: 239-244, 1978.
5. Brem, S. S., Gullino, P. M., and Medina, D. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science (Washington DC), 195: 880-882, 1977.
6. Smith-McCune, K., and Weidner, N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res., 54: 800-804, 1994.
7. Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., and Brown, L. F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst., 87: 1237-1245, 1995.
8. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
9. Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66: 1095-1104, 1991.
10. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
11. Ferenczy, A., and Winkler, B. Cervical intraepithelial neoplasia and condyloma. In: R. J. Kurman (ed.), Blaustein's Pathology of the Female Genital Tract, pp. 229-277. Berlin: Springer-Verlag, 1987.
12. Ostor, A. G. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol., 12: 186-192, 1993.
13. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comments]. J. Natl. Cancer Inst., 87: 796-802, 1995.
14. Lowy, D. R., Kirnbauer, R., and Schiller, J. T. Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA, 91: 2436-2440, 1994.
15. zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184: 9-13, 1991.
16. Vassar, R., and Fuchs, E. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev., 5: 714-727, 1991.
17. Arbeit, J. M., Munger, K., Howley, P. M., and Hanahan, D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol., 68: 4358-4368, 1994.
18. Coussens, L. M., Hanahan, D., and Arbeit, J. M. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol., 149: 1899-1917, 1997.
19. Arbeit, J. M. Transgenic models of epidermal neoplasia and multi-stage carcinogenesis. Cancer Surv., 26: 7-34, 1996.
20. Hurlin, P. J., Foley, K. P., Ayer, D. E., Eisenman, R. N., Hanahan, D., and Arbeit, J. M. Regulation of Myc and Mad during epidermal differentiation and HPV associated tumorigenesis. Oncogene, 11: 2487-2501, 1995.
21. Christofori, G., Naik, P., and Hanahan, D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endocrinol., 9: 1760-1770, 1995.
22. Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., and Ferrara, N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol., 152: 4149-4156, 1994.
23. Dvorak, H. VPF/VEGF. In: I. D. Goldberg and E. M. Rosen (eds.) Regulation of Angiogenesis. Boston: Birkhauser Verlag, 1997.
24. Senger, D. R., Van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
25. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
26. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789-1797, 1995.
27. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
28. Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol., 15: 5363-5368, 1995.
29. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA, 92: 768-772, 1995.
30. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
31. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
32. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
33. Arbeit, J., Olson, D., and Hanahan, D. Upregulation of fibroblast growth factors and their receptors during multistage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene, 13: 1847-1857, 1996.
34. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.